Interleukin (IL -6, a marker of systemIL -6flamarkern, was measured using a high-sensitivity enzyme-linked immunoforbent asystemicD Systems, Oxford, UK).
C-reactive protein (CRP) is a marker of systemic inflammation.
C-reactive protein (CRP) has been studied as a marker of systemic inflammation and outcome in a number of diseases.
Furthermore, greater thiobarbituric reactive acid substances (TBARS), a marker of systemic oxidative stress, and lipid hydroperoxide (PEROX) increases were noted in obese subjects [50, 51].
The NLR is a ratio between the absolute neutrophil and lymphocyte counts, and therefore, is a marker of systemic inflammation representative of innate and adaptive immunity.
As a marker of systemic vascular permeability, urinary ACR has been shown to have an inverse relationship with PaO2 FiO2 ratio in a cohort of trauma patients [45].
Pretreatment neutrophil-to-lymphocyte ratio (NLR) is a marker of systemic inflammation that has been associated with adverse survival in a variety of malignancies.
It has become established that C-reactive protein (CRP), a marker of systemic inflammation, is an independent predictor of CVD [13], [14].
C-reactive protein (CRP) is a non-specific marker of systemic inflammation, but whether it plays a causal role in atherosclerosis and its complications remains controversial.
CRP is an acute phase reactant and is a marker of systemic inflammation that is under direct IL-6 transcriptional control [9].
C-reactive protein (CRP), a marker of systemic inflammation, is associated with risk of coronary events and sub-clinical measures of atherosclerosis.
